POC CLINITEST Rapid COVID-19 InfluenzaAntigen Test Box with Cassette

CLINITEST COVID-19 + Influenza Antigen Test

One swab, three results–know with confidence.

When your patients present with a fever, cough, and other common respiratory symptoms, choosing the appropriate treatment requires determining the cause of their illness. The CLINITEST® Rapid COVID-19 + Influenza Antigen Test, distributed by Siemens Healthineers, enables you to detect and differentiate infections involving any combination of these three respiratory viruses at the point of care.

CLINITEST Rapid COVID-19 Antigen Test

Convenient 3-in-1 test

Test patients for SARS-CoV-2, flu A, and flu B infection with a single sample.

CLINITEST Rapid COVID-19 Antigen Test target

High sensitivity/specificity vs. PCR

SARS-CoV-2: 98.32%/99.60%
Flu A: 88.57%/97.78%
Flu B: 87.10%/97.87%

CLINITEST Rapid COVID-19 Antigen Test swab cassette

Flexible for patients and providers

Nasopharyngeal swab administered by healthcare professionals in virtually any setting, with no instrumentation or equipment required.

CLINITEST Rapid COVID-19 Antigen Test Community

Helps to Reduce Community Spread

Results can facilitate prompt self-isolation of infected patients, if deemed necessary, to prevent the spread of COVID-19 and influenza. 






98.32% (117/120)

95% CI: 94.06–99.80% 

99.60% (743/745)

95% CI: 98.83–99.92% 

99.42% (860/865)

95% CI: (98.66–99.81%) 

Influenza A

88.57% (31/35) 

95% CI: 73.26–96.80% 

97.78% (88/90) 

95% CI: 92.20–99.73% 

95.20% (119/125)

95% CI: 89.85–98.22% 

Influenza B

87.10% (27/31)

95% CI: 70.17–96.37%

97.87% (92/94)

95% CI: 92.52–99.74%

95.20% (119/125)

95% CI: 89.85–98.22%

COVID-19 illustration

Antigen Testing

  • Detects the presence of a specific viral antigen, most commonly the nucleocapsid protein
  • Typical sample types: nasopharyngeal, anterior nasal, and oropharyngeal swabs
  • Results are dependent on viral load and may not correlate with NAAT/RT-PCR results2
Flu illustration
COVID-19 Use Case

Omicron Update
Siemens Healthineers is committed to monitoring all current and emerging variants of concern (VOCs) by directly testing with clinical samples and using a computer-based inspection tool called in silico analysis. The Omicron variant (B.1.1.529) is recognized by the WHO, CDC, and ECDC as a VOC. Siemens Healthineers internal data demonstrate that the CLINITEST® Rapid COVID-19 Antigen (Self) Test detects SARS-CoV-2 virus/coronavirus infection of the Omicron variant and its major sub-variants, including BA.1, BA.2, BA.2.75, BA.3, BA.4, BA.4.6, BA.5, BF.7, and XE.